Fluralaner (CAS 864731-61-3) is an innovative insecticide and acaricide primarily utilized in veterinary medicine to protect pets, particularly dogs and cats, from fleas and ticks. Developed by Merck Animal Health, Fluralaner acts by inhibiting the functioning of the GABA-gated chloride channels in the nervous systems of these parasites, leading to their death.
For more Fluralaner CAS 864731-61-3(ar,ru,fr)information, please contact us. We will provide professional answers.
Fluralaner exhibits its efficacy by disrupting the normal neurotransmitter activity within insects and arachnids. The mode of action involves:
Veterinary experts, like Dr. Julie Buzby, emphasize the importance of using such targeted and effective treatments in ensuring a pet's health and comfort.
Fluralaner is approved for various applications in veterinary medicine. Here’s a quick overview:
| Animal Type | Indication | Duration of Efficacy |
|---|---|---|
| Dogs | Flea and tick infestations | Up to 12 weeks |
| Cats | Flea and tick infestations | Up to 12 weeks |
| Horses | Certain parasitic infestations | Varies by formulation |
Fluralaner has been extensively studied for safety in both target and non-target species. According to research published in the Journal of Veterinary Pharmacology and Therapeutics, it exhibits a favorable safety profile, which is often endorsed by veterinarians.
The safety assessments indicate:
Influencers in pet care, such as Dr. Karen Becker, often reiterate the importance of consulting with a vet before starting any treatment, including those involving Fluralaner (CAS 864731-61-3).
Are you interested in learning more about Veterinary APIs? Contact us today to secure an expert consultation!
Fluralaner has been evaluated for its environmental impact, and studies indicate that it has low persistence in the environment. This is significant when considering sustainable practices in veterinary medicine. Experts stress that responsible usage helps mitigate potential ecological risks.
In fact, leading veterinarians and ecologists recommend Fluralaner due to its targeted action, which diminishes collateral damage to non-target organisms.
Before administering Fluralaner, several important factors should be considered:
Consulting a veterinarian can provide personalized guidance, ensuring the best outcome for your pet's health.
An exciting area of research involves the potential expansion of Fluralaner’s application beyond flea and tick control. Scientists are investigating its potential effectiveness against other ectoparasites and even some endoparasites. Prominent researchers in veterinary parasitology suggest that ongoing studies may soon reveal new dimensions for this versatile compound.
Overall, Fluralaner (CAS 864731-61-3) represents a crucial advancement in veterinary therapeutics, enhancing the quality of life for pets worldwide. Its proven efficacy, safety profile, and expanding potential applications make it a noteworthy subject in veterinary medicine and pest management.
Link to Acewell
Comments
Please Join Us to post.
0